Protecting Against Postsurgery Oral Cancer Recurrence with an Implantable Hydrogel Vaccine for In Situ Photoimmunotherapy
Advanced Science · 2024-12 · 11 (46)
DOI: 10.1002/advs.202309053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 28.10.2024. Verfasst von Lan Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College …. Hauptthemen laut MEDLINE: Mouth Neoplasms, Hydrogels, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Program of National Natural Science Foundation of China, National Key Research and Development Program of China, Innovative Research Team of High-level Local University in Shanghai.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) often recurs aggressively and metastasizes despite surgery and adjuvant therapy, driven by postoperative residual cancer cells near the primary tumor site. An implantable in situ vaccine hydrogel was designed to target residual OSCC cells post‐tumor removal. This hydrogel serves as a reservoir for the sustained localized release of δ‐aminolevulinic acid (δ‐ALA), enhancing protoporphyrin IX‐mediated photodynamic therapy (PDT), and a polydopamine‐hyaluronic acid composite for photothermal therapy (PTT). Additionally, immune adjuvants, including anti‐CD47 antibodies (aCD47) and CaCO 3 nanoparticles, are directly released into the resected tumor bed. This approach induces apoptosis of residual OSCC cells through sequential near‐infrared irradiation, promoting calcium interference therapy (CIT). The hydrogel further stimulates immunogenic cell death (ICD), facilitating the polarization of tumor‐associated macrophages from the M2 to the M1 phenotype. This facilitates phagocytosis, dendritic cell activation, robust antigen presentation, and cytotoxic T lymphocyte‐mediated cytotoxicity. In murine OSCC models, the in situ vaccine effectively prevents local recurrence, inhibits orthotopic OSCC growth and pulmonary metastases, and provides long‐term protective immunity against tumor rechalle nge. These findings support postoperative in situ vaccination with a biocompatible hydrogel implant as a promising strategy to minimize residual tumor burden and reduce recurrence risk after OSCC resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, Shanghai, 200011, China.
- National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Research Unit of Oral and Maxillofacial Regenerat…
- School of Chemical Engineering and Technology, Shaanxi Key Laboratory of Energy Chemical Process Intensification, Institute of Polymer Science in Chemical Engineering, Xi'an Jiaotong University, Xi'an, 710049, China.
ORCID-Profile: Yanli Yao, Shuyang Sun
Förderung
- Key Program of National Natural Science Foundation of China
- National Key Research and Development Program of China
- Innovative Research Team of High-level Local University in Shanghai
- National High-Level Talents Special Support Plan
- "Young Talent Support Plan" of Xi'an Jiaotong University
- Natural Science Foundation of Shanxi Province
- Shanghai Municipal Health Commission Research Project
- National Natural Science Foundation of China
Zitieren
APA
Chen, L., Yin, Q., Zhang, H., Zhang, J., Yang, G., Weng, L., Liu, T., Xu, C., Xue, P., Zhao, J., Zhang, H., Yao, Y., Chen, X., & Sun, S. (2024). Protecting Against Postsurgery Oral Cancer Recurrence with an Implantable Hydrogel Vaccine for In Situ Photoimmunotherapy. Advanced Science, 11(46). https://doi.org/10.1002/advs.202309053
Vancouver
Chen L, Yin Q, Zhang H, Zhang J, Yang G, Weng L, et al. Protecting Against Postsurgery Oral Cancer Recurrence with an Implantable Hydrogel Vaccine for In Situ Photoimmunotherapy. Advanced Science. 2024;11(46). doi:10.1002/advs.202309053
BibTeX
@article{Chen2024,
author = {Chen, Lan and Yin, Qiqi and Zhang, Handan and Zhang, Jie and Yang, Guizhu and Weng, Lin and Liu, Tao and Xu, Chenghui and Xue, Pengxin and Zhao, Jinchao and Zhang, Han and Yao, Yanli and Chen, Xin and Sun, Shuyang},
title = {Protecting Against Postsurgery Oral Cancer Recurrence with an Implantable Hydrogel Vaccine for In Situ Photoimmunotherapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {46},
doi = {10.1002/advs.202309053}
}
EUVIMED